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Bone matrix synthesis and deposition play an important role in bone physioIogy.
Any disturbance can lead to several pathoIogies. We know that osteoblasts produce a
large anount of collagen and that血ose molecules are sul)Sequently crosslinked by lysyl
oxidase・ Lysyl oxidase is processed to its mature fom by procollagen C-PrOteinase
(BMP-1). TNF-α is an i血ammatory cytokine血at has multiple e飾ects on osteoblasts.
Our goal was to study the e節ects of first’a hydroxamic acid procollagen C proteinase
inhibitor provided by FibroGen Corporation’and second’the effects of TNF-α On
collagen deposition and cross-1inking by osteoblasts. In the first part of our study,
MC3T3-EI osteoblast like cells were grown in di餓nentiation medium for 15 and 20 days
in the presence or absence of the procollagen C-PrOteinase (BMP-1) inhibitor and the
amount of mature crosslinks (ftyd/Dpd) was assessed by enzyme immuno assay・ In the
second part of our study, MC3T3-EI cells were grown in differentiation medium in the
presence or absence of TNF-α for 24 hours and subsequently pulsed labeled with tritiated
proline fbr 2 hours・ A collagen synthesis assay was perfomed to evaluate the amount of
collagen peptides produced. Our data shows that the procollagen C-PrOteinase i血ibitor at
20 and 50いM may increase abnomal collagen deposition but doesn’t seem to modify
much the mature collagen cross-1inking process. TNF-α has l珊e or no e餌知On CO11agen
synthesis. Other lysyl oxidase iso enzymes’nOt affected by our BMP-1 inhibitor, may be
invoIved in mature crosslink production. TNF-α,s e前知s on collagen are mainly
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α一MEM: AIpha modified Eagle’s mediun
BAPN: β一aminopropionitrile
BSA : Bovine serum albunine fraction V
FBS: Fetal Bovine Serum
DMEM : Dulbecco’s mod綿ed Eagle’s mediun
PBS : Phosphate-buffered saline
DMSO: Dimethyl sulfoxide
BMP : Bone moaphogenetic protein
Pyd: Pyridinoline
Dpd: Deoxypyridinoline
TNF-α: Tunor necrosis factor alpha
TGF-β: Transfoming grow血factor beta
mRNA: Messenger ribo肌Cleic acid
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LITERATURE REVIEW
11 Bone Collagen structure and biosynthesis:
90% of the organic matrix of bone is collagenous (Wiestner et al., 1981). Type I
collagen is made of 3 alpha polypeptide chains which have a repetitive Gly-X-Y motif X
is often a proline and Y a proline or an hydroxyproline residue (Kielty et al., 1993)・
Collagen polypeptide chains contain uncommon amino-aCids including 4-hydroxyproline’
3-hydroxyproline and 5-hydroxylysine (Kielty et al., 1993)・ The co11agen alpha helix is
unique because it o血y has 3.3 residues per tum instead of 3.6 (Ramachandran, 1988)・
These alpha polypeptide chains are wound toge血er in a right tum triple helix which is
stabilized by hydrogen bonds from血e hydroxyprolyl residues (Ranachandran, 1988).
Type I co11agen is the m衰ior form in bone and consists of two α1 (COLIAl) chains and
one α2 (COLIA2) chain (Kadler, 1994; Miller, 1976; Vuust, 1975)・ Sma11 amounts of
type V co11agen are present as well (VOn der Mark, 1999).
Collagen mRNAs are translated into prepro-alpha polypeptide chains on血e rough
endoplasmic reticulum. The nascent polypeptides accunulate in the lumen of the
endoplasmic reticulun. Concomitant wi血translation selected prolyl and lysyl residues
are hydroxylated by prolyl and lysyl hydroxylases respectively (Kivirikko and RIsteli,
1976). Ferrous ions, 2-OXOglutarate, OXygen and ascorbate are needed for the enaymes to
work (Kielty et al., 1993). Selected hydroxylysyl residues are glycosylated with glucose
and galactose by glucosyl and galactosyl transferases respectively (Kivirikko and Risteli,
1976). Non covalent interactions between血e C-teminal propeptides of血e血ee pro一
1
alpha chains occur (Kielty et al., 1993). Later on intra and inter chain disu脆de bonds
fom in the C-teminal non helical pro-PePtide extension of the pro-alpha chains catalyzed
by the enayme protein disulphide isomerase (Myllyla et al., 1983). They allow the 3 pro-
alpha chains to assemble in a triple helix from the C to the N teminal part ofthe molecule
(Bachinger et al., 1981). Peptidyl-PrOlyl cis-tranS isomerase and a collagen speci宜c
Chaperone including HSP47 facilitate血is association (Gelse et al., 2003; Koide et al・,
2000; Lamande and Bateman, 1999). Once the triple-helix confomation is obtained the
maturing pro-COllagen is transported from the endoplasmic reticulun to the Golgi
apparatus and is then secreted. The N and C teminal propeptides are subsequently
Cleaved by specific N and C procollagen peptidases (Prockop et al., 1998).
Once the polypeptides are cleaved the collagen molecules (-300 kDa) pack into
fibrils due to hydrophobic interactions (Piez, 1982). They associate head to tail in a
Parallel array and overlap each other by about 3竹of their length in a staggered pattem
(Kielty et al., 1993). Intra-mOlecular and inter-mOlecular crosslinks initiated by lysyl
OXidase activity subsequently reinforce this arrangement (Eyre, 1987). Once the collagen
molecules are fully packed and crosslinked the fibrils are no Ionger soluble. A
recapitulative view of the whole process can be seen in Figure l (Fig. 1).
In order to remove abnomally folded collagen chains that could interfere wi血
nomal fibril fomation, Pathways exist for removmg血ese potentially dangerous
molecules. For example, HSP 47 (Nagata, 1998), PrOly1 4 hydroxylase (Walmsley et al・,
1999) and protein disulphide isomerase (Bottomley et al., 2001) retain in血e endoplasmic




Fig. 1 : Collagen Biosynthesis and assembly. Collagen mRNAs are translated into prepro-
alpha polypeptide chains on the rough endoplasmic reticulum. In the lunen of the
endoplasmic reticulum selected prolyl and lysyl residues are hydroxylated and selected
hydroxylysyl residues are glycosylated with glucose and galactose. Non-COValent
interactions between the C-teminal propeptides of the t血ee pro-alpha chains occur and
intra and inter chain disulfide bonds fom. The 3 pro-alpha chains assemble in a正ple
helix from the C to the N teminal part of the molecule. After that,血e maturing pro-
COllagen is transported from the endoplasmic reticulun to血e Golgi apparatus and
ultimately secreted. The N and C teminal propeptides are subsequently cleaved by
SPeCific N and C procollagen peptidases. The collagen molecules pack into fibrils,
associate head to tail in a para11el array and staggered pattem. Intra-mOlecular and inter-




Lysyl oxidase was discovered in 1968 (Pimell and Martin, 1968). Lysyl oxidase is
not synthesized as a mature enayme but as a 50 kDa pro-1ysyl oxidase that needs to be
processed extra cellularly by BMP-1 and related pro-COllagen C proteinases such as
mTLD, mTLL-1 and mTLL-2 to fom the active 30 kDa enzyme and an 18 kDa
PrOPePtide (Panchenko et al., 1996; Smith-Mungo and Kagan, 1998; Uzel et al., 2001)・
Lysyl oxidase oxidatively deaninates peptidy1 1ysine and hydroxy-1ysine residues (Bailey,
1974). Lysyl oxidase requires copper (Siegel et al., 1970) as cofactor・ Ano血er cofactor
was initially thought to be vitamin B6 (Murray and Levene, 1977). It was later on
postulated that the carbonyl cofactor of lysyl oxidase was pyrroIoquinolinequinone (PQQ)
or a similar compound (Williamson et al., 1986). More recently, Wang et al・ Showed that
the quinone cofactor actually derived from the K CrOSSlinking of a modified tyrosine
residue to the epsilon-amino groxp of a lysyl side chain ” and identi宜ed it as lysine
tyrosylquinone (LTQ) (Wang et al・, 1996).
Lysyl oxidase acts only xpon telopeptide lysine residues opposite a highly
conserved amino-aCid sequence in the N and C teminals of an a句acent collagen molecule




3.1 / Inter co量lagen chains crossIinking
3.1.1/ Immature cross獲inks formation
Lysyl oxidase can oxidatively deaninate a telopeptide hydroxylysyl residue to
fom a hydroxylysyl aldehyde (Fig. 2). This hydroxylysyl pathway is predominant in bone
(Kielty et al., 1993).
Once an allysine is fomed crosslihking proceeds spontaneously wi血out further
enaymatic catalysis. The telopeptide allysine can spontaneously condense with either an
helical lysine or an helical hydroxylysine to fom an unstable Sch鮒base which undergoes
a spo血meous Amadori rearrangement respectively leading to lysinoketonorleueine and
hydroxylysinoketonorleucine (Knott and Bailey, 1 998)(Fig. 3)
Both hydroxylysinoketonorleucine (HLKNL) and lysinoketonorleucine (LKNL)
Can be stabilized by reduction with borohydride to respectively fom
dihydroxylysinonorleucine (DHLNL) and lysinohydroxynorleucine (LHNL) (Knott狐d
Bailey, 1998).
Lysyl oxidase can also oxidatively deaninate a telopeptide lysyl residue but lysine
aldehyde derived cross-1iIks are less common in bone. The telopeptide lysine aldehyde
Can Subsequently condense with either helical lysine or hydroxylysine residues to fom
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Fig.2 : Lysyl oxidase catalyzes the oxidative deamination of a telopeptide 5-hydroxylysyl
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Fig 3. The telopeptide allysine can condense with ei血er a helica=ysine or a helical
dydroxylysine residue to fom an unstable Schiff base which undergoes a spontaneous
Amadori rearrangement respectively leading to lysino　5-keto norleucine and
hydroxylysino 5 -ketonorleucine residues.
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3.1.2/ Mature cross-量inks formation:
LKNL and HLKNL are divalent immature cross-1inks between an N or C
telopeptide domain and a triple helical portion of two co11agen molecules. Mat皿e CrOSS-
1inks in collagen are trifunctional. Pyridinolines are the m劉Or mature CrOSS-1i重ks.
Hydroxylysyl pyridinoline commonly referred to as pyridinoline (Pyd) is composed of
two hydroxylysyl aldehyde residues and a helical hydroxylysine. It is postulated to result
from血e condensation of an HLKNL cross-1ink with an hydroxylysine aldehyde from
another collagen molecule (Robins and Duncan, 1983),(Fig. 4). Lysyl pyridinoline
COmmOnly referred to as deoxypyridinoline (Dpd) is composed of two hydroxylysyl
aldehyde residues and a helical lysine. It is believed to originate from the condensation of
an LKNL cross-1ink with an hydroxylysine aldehyde from ano血er collagen molecule
(Ogawa et al., 1982), (Fig. 4). These pyridiniun cross-1inks are acid stal)1e and ultraviolet
SenSitive compounds (Hanson and Eyre, 1996). Ano血er trifunctional cross-1ink, the
PyrrOle cross-1ink, has been detected by its reaction w皿E血Iich’s reagent. It’s chemistry
and occurrence is still disputed. Knypers et al. postulated that it could derive from










Robin§ and Duncan, 1983
中ソ富巾「首di雨ine
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Fig 4. Lysyl Piridinoline or deoxypyridinoline (Dpd) and Hydroxylysyl Pyridinoline or
Pyridinoline (Pyd) fomation缶om LKNL and HLKNL respectively
ノ
Fig 5. The structure ofthe pyrrole crosslink as postulated by Kuypers et al., 1992
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3.2/ Intra collagen chains cro§Slinking:
Collagen fibrils can be further stabilized by intra tropocollagen molecule
crosslinks. Evidence of such crosslinks was demonstrated by Bomstein et al・ in 1966
(Bomstein et al., 1966). The intra-mOlecular crosslinking process starts with two lysyl
residues from either the C or N terminal telopeptide・ They are oxidative量y deaminated by
lysyl oxidase to fom allysine residues. The aldehyde groups of the allysine residues can
spontaneously undergo an aldoI condensation・ This aldoI can then react with histidine to
fom血e aldol histidine which can react further wi血5-dydroxylysine to fom histidine
dehydrohydroxymerodesmosine, a Sch紺base (imine link) (Bemstein and Mech狐ic,
1 980). A tetrafunctional crosslink is made.
4/ Inhibition of Lysy量oxidase:
In 1962, Smiley et al. concluded that伍BAPN acts by blocking the fomation of
mature collagen fibers perhaps by preventing瓜e cross-1inkage between α-COllagen
chains” (Smiley J. D, 1962). Its irreversible i血ibition of lysyl oxidase activity (Ki of 3-5
叫M) was demonstrated later O{arayanan et al., 1972)・ BAPN covently binds to血e active
site of lysyl oxidase and doesn’t seem to alter its copper content (Tang et al., 1983). It is
therefore commonly used to specifically i血ibit lysyl oxidase.
Several other compounds were found to irreversibly i血ibit lysyl oxidase: B-
haloanines which i血ibit lysyl oxidase faster than BAPN and B-nitroetdylamines which
間
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are weaker (Tang et al., 1984), Vicinal diamines such as cis-1 ,2-dianinocycIohexane and
etdylenediamine as inhibitors of pyrroIoquinoline qumOne Which was thought to be血e
Carbonyl cofactor of lysyl oxidase (Gacheru et al., 1989), CyCIopropylanine (Shch et al.,
1 993), homocysteine thiolactone, Selenohomocysteine lactone, homoserine lactone (Liu et
al., 1997) and aminoalkylaziridines (Nagan et al., 1998).
Heparin was also found to be a lysyl oxidase inhibitor (Gavriel and Kagan, 1988).
High doses of zinc have been shown to in血bit in vivo lysyl oxidase (Chvapil and
Misiorowski, 1980) and umefined avocado oils also diminish lysyl oxidase activity
(Werman et al., 1991).
5 /Regu量ation of Lysy獲Oxidase:
In MC3T3-El osteoblast like ce11s TGF-β1 increased steady state lysyl oxidase
and COLIAl mRNA levels in a dose- and time-dependent mamer (Feres-Filho et al.,
1995; Hong et al., 1999). TGF-β1 acts in a similar mamer on MG-63　hunan
OSteOSarCOma Cells (Lee et al., 1 997).
On血e contrary, MC3T3-EI osteoblast like cells treated with basic fibroblast
growth factor down-regulated lysyl oxidase and COLIAl mRNA levels by 70% and 90%





Procollagen C-PrOteinases process procollagen molecules to collagen by cleaving
the C-teminal domain and releasing the C-teminal propeptides. An 80 kDa enayme
e舐鵜tive on type I, II and IⅡ procollagens was isolated by N蒔ha in 1982 from
membranous bones of chick embryos (Njieha et al., 1982). In 1985, HQjima et al. isolated
a 97 to l lO虹)a procollagen C-PrOteinase from chick embryo tendons (HQjima et al.,
1985). From mouse fibroblasts Kessler et al. isolated a lOO fold purified 125 kDa enayme
that would cleave pro alpha l(I) and pro alpha 2(I) chains at the physioIogic site i.e. the
Ala-Asp bond and pro alpha I(IⅡ) chain at血e specific Gly“Asp bond (Kessler et al・,
1986). Later on they isolated an 80 kDa enzyme which had been purified 18500 fold
(Kessler and Adar, 1989). Takahara et al. isolated a 70 kDa enzyme (Takchara et al.,
1994). In fact, t血ee foms of血e active protein can be identified: a 70 kDa polypeptide, a
80 kDa polypeptide containing m addition to the 70 kDa polypeptide a histidine-rich
SequenCe and a lOO kDa polypeptide (Prockop et al” 1998).
Panchenko showed that procollagen C-PrOteinase cleaves the 50 kDa pro-1ysyl
OXidase substrate into the active 30 kDa lysyl oxidase enzyme and an 18 kDa propeptide
in the extra cellular space (Panchenko et al., 1996).
13
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6.2 / Procollagen C-PrOteinase inhibition
Cadmiun is a strong procollagen C-PrOteinase i血ibitor. Cxpric and zinc ions only
i血ibit the purified enzyme (Hqiima et al., 1994). Other molecules invoIved in PCP
inhibition will be seen later on (See SeCtion 7.2.4).
6.3 / Procollagen C-PrOteinase enhancer protein (PCPE)
Proco11agen C-PrOteinase is o血y present in sma11 amounts and camot accouut for
the rapid procollagen to collagen processmg. Adar et al. discovered a glycoprotein血at
enhanced the enzyme activity by approximately four fold, the procollagen C-PrOteinase
enhancer protein. Two molecular weights were found: 34 and 36 kDa (Adar et al., 1986)・
Four active forms were found: 55 kDa, 36 kDa, 34 kDa and a 16.5 kDa (Adar et al., 1986;
Kessler and Adar, 1989; Mott et al., 2000). The protein consists of two CUB domains in
the N-teminal region (Takahara et al., 1994) and has a netrin like domain (NTR domain)
in the C-teminal region (Banyai and Pa請hy, 1999). It looks like a rod-1ike molecule of-
150 Å wi血a maximun width of- 60 Å (Bemocco et al., 2003). PCPE can e血ance by up
to 20 fold PCPs activity (Hulmes et al., 1997; Kessler and Adar, 1989) and it was shown
to be a property of血e CUB region (Hulmes et al., 1997)・
It has been suggested that when PCPE binds to the collagen C-PrOPePtide a
COnfomational change occurs which facilitates access of PCP (Adar et al・, 1986). The
StOichiometry of the PCPE佃rocollagen C-PrOPePtide interaction was found to be l :1
(Moschcovich et al., 2001 ; Ricard-Blun et al., 2002). Binding of PCPE to the procollagen
C-PrOPePtide is dependa血t on divalent cations such as calcium that bind to血e C-
14
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PrOPePtide (Ricard-Blun et al., 2002) but PCPE binding may not be limited to the C-
ProPePtide reglOn aS the interaction appears to be stronger when the procollagen molecule
is intact (RIcard-Blum et al., 2002).
Although the main function of PCPE is to enhance PCP activity, it was shown that
its 16.5 kDa fom or C-teminal NTR domain moderately inhibited MMP2 and “may
COnStitute a new class of meta1loproteinase i血ibitor” (Mott et al., 2000)・
7 / Bone Morphogenic Protein - 1
7.1/ Overview on Bone Morphogenic Proteins
Ectopic bone formation was shown by Dr Marshall Urist in an experiment in
Which he transplanted demineralized bone in a rabbit muscle. He called the protein
responsible for this phenomenon “bone morphogenic protein”(Urist, 1965). The protein(S)
inducing bone formation were not ident綿ed until Wozney et al. isolated three cDNA
CIones: BMP-1, BMP-2A and BMP-3 (Wozney et al., 1988). BMP-2A and BMP-3 were
found to be new members of the TGF-β supergene family whereas BMP-1 was thought to
be “a novel regulatory molecule”(Wozney et al., 1988). Not much latter, five additional
BMPs were identified (Celeste et al., 1990; Lyons et al., 1991). As of today, Sixteen
BMPs were reported but there might be orphan BMPs still to be found. Almost all of them
belong to the TGF-β supergene family, the one exception being BMP-1.
15
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7.2 / Bone Morphogenic Protein -1
BMP-1 is a proteinase belonging to the astacin family of metalloendopeptidases
(Bond and Beynon, 1995) and is derived from mammalian tolloid (Takahara et al., 1995).
Its C-terminal domain contains an epidermal growth factor like domain and three
Clr/CIs, Uegf; and Bmpl (CUB) repeats (Bond and Beynon, 1995; Bork and Beckmam,
1993).
7.2.1 / Functions of BMP-1
Although its function was unclear a‖血st, BMP-1 has multiple functions. It can
Cleave chordin and precursors of extracellular matrix proteins.
Cleavage of chordin, a BMP antagonist, by BMP-1 counteracts its dorsalizing
effects (Mullins, 1998; Scott et al., 1999) and allows BMP-1 to control the dorso-Ventral
Patteming in vertebrates. ( The minimal structure for chordinase activity comprises a
metalloproteinase domain and the CUB-1 domain of BMP-1 ) (Petropoulou et al” 2005).
BMP-1 cleaves the C-teminal propeptides of procollagen I, II, III (Kadler et al.,
1996; Kessler et al., 1996; Prockop et al., 1998),血e N-teminal globular domain and C-
teminal propeptide ofprocollagen V (Kessler et al., 2001 ; Unsold et al., 2002) and the C-
teminal propeptide of proco11agen VⅡ (Colombo et al., 2003; Rattenho11 et al., 2002) and
therefore allows deposition of the collagen fibrils in the extracellular matrix.
BMP-1 also removes the propeptide from probiglycan and produces biglycan, a
Small leucine rich proteoglycan that may have “a positive regulation of bone fomation”
(Scott et al., 2000).
16
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Laminin-5 is also processed by BMP-1(Amano et al., 2000; Veitch et al・, 2003)・ In
doing so, BMP-1 facilitates basal membrane assembly and regulates血e adhesion and
migration of epithelial cells.
Of particular interest for our research, BMP-1 can process the lysyl oxidase pro-
enayme and is血erefore invoIved in血e cross-1ihking of both collagen and elastin (Borel
et al., 2001; Panchenko et al., 1996; Uzel et al., 2001).
7.2.2 / Is Bone Morphogenic Protein-1 the Procollagen C-PrOteinase?
Several authors have shown血at BMP-1 is in fact血e proco11agen C-PrOteinase
both using peptide sequencing of a purified protein and immunoIogical cross-reaCtivity
(Kessler et al., 1996; Li et al., 1996). It was later on shown that “the CUB2 domain is
essential for procollagen C-PrOteinase activity of BMP-1” (Hartigan et al., 2003;
Petropoulou et al., 2005) and that inside the CUB2 domain, Glu-483 was “critical for
PrOCOllagen C-PrOteinase activity of BMP- 1 ” (Ha血gan et al・, 2003).
7.2.3 / Regulation of BMP-1
TGF一β was shown to elevate BMP-1 mRNA levels by 7 fold in MG-63
0SteOSarCOma Cells (Lee et al., 1997).
17
ノ
7.2.4 / Inhibition of BMP-1/PCP
Glutamic acid derived hydroxamates were iden組ed as potent and selective
inhibitors of procollagen C-PrOteinase (Dankwardt et al., 2001 ; Robinson et al., 2003). An
hydroxamate containing compound, FG-HLl (FibroGen, South San Francisco, CA, USA),
WaS Shown to block gastrulation in the sea urchin embryo (Huggins and Lennarz, 2001).
8/ Tumor Necrosis Factor - α
8. 1/ Overview
In 1975, Carswell et al. isolated a factor released by the host, tumOr neCrOSis
factor一α, CaPable of mimicking the e鮒鵜tS Of endotoxin in causmg the necrosis of the
SarCOma Meth A (Carswell et al., 1975). TNF-α is a pleiotropic inflammatory cytokine
(Tracey and Cerami, 1994). It does cause the necrosis of some tumors but may also
Stimulate some others.
8.1.11 0rigin
TNF-α is mainly released by the macrophages and monocytes (Tracey and
Cerami, 1990) but fibroblasts (Havell and Rogerson, 1993), keratinocytes (Haas et al・,
1992), endothelial cells (Freyer et al., 1999), aStrOCyteS (Chung and Benveniste, 1990),
18
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granulocytes (Mandi et al., 1991), adipocytes (Sewter et al., 1999), lymphocytes (Sung et
al., 1988) and plasma cells (Di Girolamo et al., 1997) can also produce TNF-α.
8. 1.2/ Structure
TNF-α is a trimeric protein (Wingfield et al., 1987). In its secreted fom each
monomer weights 17 kDa (Eck and Sprang, 1989), is composed of 157 amino acids
residues and contains one disulphide bond (Aggarwal et al., 1987) and has a beta-
Sandwich secondary st則Cture fomed by two and-Parallel beta-Pleated sheets (Jones et al.,
1990)・ Further research showed that a 26 kDa transmembrane form is also active (Perez et
al., 1990)・ In fact, TNF一α is expressed on the cell membrane as a bioactive 26 kDa protein
Which can be cleaved into its 17 kDa soluble fom by a specific TNF-α COnVerting
enzyme (TACE), a member ofthe MMP family (Black et al., 1997; Moss et al., 1997).
8. 1.3/ TNF-α reCePtOrS
TNF-α has two transmembrane receptors, TNF-Rl (P55) and TNF-R2 (P75). They
each consist of a disu脆de rich domain w址ch recogmzes TNF-α, a tranSmembrane helix,
and a cytoplasmic domain (Naismi血and Sprang, 1995; Tartaglia and Goeddel, 1992),
TNF-α Can also bind to soluble forms of the receptors: STNF-Rl (Corti et al., 1995b) and
STNF-R2 (Corti et al., 1995a).
星図 19
8.1.4/ TNF-α Inducer§
Bacterial endotoxins such as lipopolysaccharide can potentiate TNF一α and initiate
their release from the macrophages (Freudenberg and Galanos, 1990; Tracey and Cerami,
1993). For instance LPS was shown to induce hemorrhagic necrosis by locally i巾ected
TNF-α in the normal skin whereas TNF-α alone did not have any e餌∋Ct (Rothstein and
Schreiber, 1987). Viruses (Orzechowska, 1999), immune complexes (Hart et al., 2004;
Kim et al., 1991) and interleukins such as IL-2 (Nedwin et al., 1985) and IL-12 (Jana et
al., 2003) can also induce TNF-α. TNF-α Can also be released by autocrine/paracrine
TNF一α induction (Smith et al., 1990a).
8.1.5/ TNF"α Properties
TNF-α has multiple properties. It can stimulate the acute phase response (Gresser
et al., 1987) and catabolism in general (FIores et al., 1989; Green et al., 1994)・
TNF-α Can mOdulate the expression of several genes (Schutze et al., 1992)・ For
instance, TNF-α Stimulates the gene expression for several growth factors such as nerve
growth factor (Hattori et al., 1996), angiogenic growth factors l and 2 (Hangai et al.,
2006). It can also up regulate the gene expression of many cell su血ce receptors such as
IFN-γ reCePtOrS (Sanceau et al., 1992), IL-2 receptors (Munoz-Femandez et al., 1992), IL-
3 receptors (Goto et al., 1995), IL-4 receptors on murine sarcoma cells (Puri and Leland,
1993), Platelet-aCtivating factor receptor (Dagenais et al., 1997), VaSCular endo血elial
growth factor receptor-2 and its co-reCePtOr neurOPilin-1 (Giraudo et al., 1998) and
/ノ
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several o血ers. Transcription factor genes such as AP-1 (Kyriakis, 1999), NF-kappaB
(Tian et al., 2005) are also up regulated by TNF-α・ On the other hand TNF-α SuPPreSSeS
the activdy ofthyroid transcription factors TTF-1 and Pax-8 (Ohmori et al., 1999).
TNF-α Plays a mapor role in the host defense against infections and tumor growth
(Beutler and Cerami, 1989). TNF-α invoIvement in host defense was shown in the
fctlowing bacterial infections: αlan少da t71aChomatis (Wi11ians et al., 1990),
Hお印p楊sma c呼sulata/m (Smith et al., 1990b), Sんや砂lococci (Vauda雌et al., 1992),
助h#S rickettsiae (Geng and Jerre11s, 1994), Rlebsiella pneumonia (Laichalk et al.,
1996), Pneumo少tis carinii (Limper, 1997) and nycobacteria (Olleros et al., 2005).
Although slightly controversial (Ste触正et al., 1996), TNF-α is a likely
endogenous pyrogen (Dinarello et al., 1986; Ste餓nd et al., 1996)・
TNF一α also plays a role in lymph node development and neo-OrganOgeneSis in the
PreSenCe Of a chronic infection (Ruddle, 1999)・
8.2/ E倣うCtS Of TNF-α On OSteOblasts
Osteoblast d鮒erentiation is inhibited by TNF-α (Gilbert et al., 2000)・ An
important transcription factor invoIved in osteoblast differentiation’ runt-related
transcription factor 2 (RUNX2) or core binding factor alphal (Cbfal), WaS ShoⅧ tO be
i血ibited by TNF一α (Gilbert et al., 2002) via mechanisms requiring TNF-α reCePtOr l
(Abbas et al., 2003; Gilbert et al., 2005). Another osteoblast di餌nentiation factor,
transcription factor osterix (Osx), WaS Shown to be down regulated by TNF-α (Lu et al.,
Markers of osteoblast di鮮料entiation, Such as alkaline phosphatase and matrix
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deposition are also i血ibited by TNF-α・ TNF一α decreases alkaline phosphatase activity by
20-30% (Centrella et al・, 1988; Nakase et al・, 1997; Sato et al., 1987) and inhibits co11agen
incorporation (Centre11a et al., 1988; Panagakos et al., 1994). In mature osteoblasts, TNF-
α also inhibits the production of bone matrix proteins such as IGF葛1 at the mRNA level
(Gilbert et al., 2000; Scharla et al., 1994)・ Mineral deposition is also inhibited by TNF-α
(Panagakos et al., 1996).
Bone fomation may be limited by TNF-α induced osteoblastic apoptosis (Hill et
al., 1997; Kitajima et al・, 1996) but only TNF-α reCePtOr l (p55) is invoIved in TNF一α
mediated apoptosis (Gilbert et aL, 2005).
TNF-α　may also promote matrix degradation by e血ancing matrix
metalloproteinases production・ ( TNF-α alters the balance between urokinasertype
Plasmino gen activator佃1 asmino gen activator inhib itor- 1　and matrix
metalloproteinases砧ssue i血ibitor of metalloproteinases l , Which favors higher activity of
PrOteinases ” (Panagakos and Kunar, 1 995).
TNF-α i血ibits l ,25-dihydroxyvitanin D3 e鮮edts on osteoblastic ce11s (Nanes et
al., 1991) and K POtently down-regulates osteocalcin promoter function 》 (Li and
Stashecko, 1992). Mayur et. al showed that TNF-α,s action included inhibition of
intracellular l ,25 -dihydroxyvitanin D3 receptor at血e mRNA level (Mayur et al., 1993).
In fact, TNF-α decreases binding of the vitamin D receptor (VDR) to the vitamin D
response element (VDRE) of the osteocalcin gene (Femandez-Martin et al., 1 998). TNF-α
also increases cycIooxygenase-2 mRNA levels (Xu et al., 1997) and therefore increases
PGE2 synthesis (Sato et al・, 1987) which further in血bits the stimulatory action of l,25-
dihydroxyvitamin D3 on osteoblasts and osteocalcin production (Evans et al., 1 990).
各回
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TNF-α　Can Stimulate bone resorption by enhancing osteoclast fomation
(Pfeilschifter et al., 1989). The receptor activator of nuclear factor kappaB ligand,
ENKL, is stimulated under TNF一α COnditions and synergistica11y enhances its e餌鵜ts on
OSteOClastogenesis (Komine et al., 2001). TNF receptor-aSSOCiated factor 2 (TRAF2), a
Slgnal transducer for RANK, TNFRl and TNFR2, is an important mediator in TNF-α
induced osteoclastogenesis (Kanazawa and Kudo, 2005)。
8.3 / TNF“α invoIvement in post menopausal osteoporosis
Postmenopausal osteoporosis is characterized by a decrease in bone mass and an
increased risk of fracture fo11owing ovarian failure. In a surgica11y induced menopause
model Pacifici et al. showed that TNF-α levels statistically increased 2 weeks post surgery
and plateaned at 8 weeks if estrogen replacement血erapy wasn’t introduced (Pac綿ci et
al., 1 99 1). They also found that hydroxyproline/creatine and calcium/creatinine ratios, tWO
urinary markers of bone resoaption, Were COrrelated with TNF-α levels (Pacifici et al.,
1991)・ More recent markers, urinary pyridinoline (Pyd) and deoxypyridinoline (Dpd),
Were found to be more spec範c markers of bone matrix degradation (Seibel et al., 1993).
Several studies confirmed TNF一α invoIvement in postmenopausal osteoporosis.
For instance, Kimble et al. showed that in ovariectomied mice, TNF binding protein, an
inhibitor of TNF-α, PreVented bone loss (Kimble et al., 1997) and Roggia et al. found that
TNF-α knock-Out mice (TNF-/-) do not lose bone after ovariectomy (Roggia et al., 2001;
Roggia et al., 2004).
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9/ Diseases associated with a reduced lysyl oxidase activity
Several diseases are associated with a reduced lysyl oxidase activity.
Copper is an important cofactor of lysyl oxidase and may be deficient
nutritional ly.
Menkes syndrome and the occipital hom syndrome (Ehlers-Danlos syndrome type
IX, X-1inked cutis laxa) are two X-1inked recessively i血erited disorders血at lead to
abnomalities in copper transport and contribute to lysyl oxidase deficiency・
Lathyrism is, On血e o血er end, CauSed by BTaninoproprionitrile (BAPN), a POtent
irreversible inhibitor of lysyl oxidase (Narayanan et al・, 1 972)・
9.1 / Nutritional copper de範ciency
MaIked changes in bone collagen crosslihking and presumわly lysyl oxidase
activity were found when copper administration is reduced (Rucker et al., 1977). Bone
chick lysyl oxidase activity was correlated with dietary copper (Opsahl et al., 1982). In
rats deprived of copper, K the functional activity of lysyl oxidase in skin was one一也ird to
One-halfthe nomal values ) (Romero-Chapman et al., 1991).
9.2 /Menkes syndrome and Occipita看hom syndrome
Bo血are X-1inked recessively inherited disorders characterized by abnomalities in
copper metal)Olism, the occipital hom syndrone being less severe. A lyayl oxidase
deficiency was found in the X-1inked fom of cutis laxa or occipital hom syndrome (Byers
「al ’
1980). Likewise a decrease in lysyl oxidase activity concomitant wi血elevated
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COnCentrations of cellular cqxper and血erefore a ftmctional intrace11ular cQPPer deficiency
WaS found in Menkes syndrome (Royce et al., 1980). In the skin and aorta lysyl oxidase
activity was found to be “o血y 6-12% ofnormal” in cases of Menkes disease (Royce and
Steirmam, 1 990).
Copper is not transported from the cytosol to血e Golgi apparatus and is therefore
not availal)1e for proper lysyl oxidase activity. Mutations in血e ATP7A gene血at codes
for copper transporting ATPases Iocated in the trans Golgi network were found in bo血
diseases. According to血e extent of ATP7A gene mutations a severe or milder fom ofthe
disease develops - Menkes disease or Occipital hom disease respectively (Moller et al.,
2000; Seidel et al., 2001).
9.3 / Lathyris血
It is a disorder linked to excessive consunption of the sweet pea La吻欄s sativus
and its related plants (Lat砂rus odorat郷, Lat砂r2/S OChrus, Lat砂rus ochrus, Lat砂rus
Cicera and Lat砂rus cb′menunがThe association between血e disease and ingestion of
peas was already described by Hippocrates・ The main poISOn invoIved is probal)1y血e
glutamate analogue beta-(N)-OXalylamino-L-alanine acid (BOAA), a POtent agOnist of
glutamate receptors in the nervous system (Spencer and Schaunburg, 1983)・ Lat砂rus
Oくねratus consumption may lead to skeletal changes. It contains the toxic B-(γ-glutamyl)
aninoproprio血trile which is an irreversible inhibitor of lysyl oxidase once metal)Olized to
B-aminoproprio血trile (BAEN) (Smi血-Mungo and Kagan, 1998). JiAPN may also be
†POnSlbl e
for osteolathyrism after Lat砂rus sativ”S COnSunPtion. Lysyl oxidase
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i血ibition diminishes collagen and elastin cross-1inks. It leads to several comective tissue
disorders, Which translate in the bone with pain and defomities (exostosis).
10/ Diseases associated with an enhanced lysyI oxidase activity
Several宜brotic diseases such as atherosclerosis’lung’liver and kidney fibrosis are
associated with an increased lysyl oxidase activity. The enzyme is also increased during
WOund healing.
Atherosclerosis is characterized by the deposition of atheromatous plaques
COntaining cholesterol and lipids on the innermost layer of arterial walls. In a rabbit model
Of atherosclerosis Kagan et al. showed a dramatic increase in lysyl oxidase activity when
the animals were fed with an atherosclerotic diet (Kagan et al., 1981).
mlmonary fibrosis is scamng Of the lungs・ It may be caused by several conditions
SuCh as sarcoidosis’hypersensitivity pneumonitis, aSbestosis, and certain medications or
may be idiopathic. In rats’bleomycin induces pulmonary fibrosis. A dramatic increase in
lysyl oxidase activity was found after bleomycin treatment (Counts et al., 1981). Under
experimental silicosis in rats, the enzyme activity was also augmented (Poole et al., 1985).
Cadmium inhalation also lead to fibrosis and was shown to enhance lysyl oxidase activity
(Almassian et al., 1991).
Liver fibrosis may be caused by several envirormental factors such as alcohoI
COnSunPtion, Virus infection and chemical age血S and may lead to cirrhosis over time. An
increase in lysyl oxidase activity was demonstrated in cases of chronic liver fibrosis
(Wckascki and Ooshima, 1 990).
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Di Donato et al. showed that an “ increased expression of lysyl oxidase in the
kidney precedes the development of diffuse fibrotic lesions x> (Di Donato et al., 1997).
In the early stromal stage of ductal breast carcinoma, an increase in lysyl oxidase
activity was also found (Decitre et al., 1998).
An increase in lysyl oxidase activity is not limited to fibrotic diseases or
COnditions. In a neurodegenerative disorder such as amyotrophic lateral sclerosis the lysyl
OXidase gene was found to be up regulated and probably associated with the progression
Of the neurodegenerative disease (Li et al., 2004).
11/ 0助ectives
Phenotypically normal osteoblasts produce large amounts of collagen. Those
molecules are subsequently highly cross-1inked by lysyl oxidase and later on
mineralization of the bone matrix can occur. Complete inhibition of lysyl oxidase activity
by BAPN for instance leads to osteolathyrism and disturbs bone and cartilage formation.
Procollagen C proteinase inhibitors inhibit the enzyme processmg lysyl oxidase to its
mature form. It can be expected, therefore, that inhibition of procollagen C-PrOteinases
WOu獲d also inhibit collagen deposition. TNF-α is an inflammatory cytokine that has
multiple e餌鵜ts on osteoblasts and is elevated in osteoporosis. We wished to actually
determine the e餓∋CtS Of first, a PrOCOllagen C proteinase inhibitor made of hydroxamic
acid derivatives provided by FibroGen, and then TNF-α On CO11agen deposition and cross-




AIpha Modified Eagle’s Mediun (α-MEM), Dulbecco’s Modified Eagle’s
Mediun, Dulbecco’s phoaphate buffered saline, BGJb mediun, fetal bovine serum (FBS),
penici11in, StrePtOmyCm, nOneSSential anino acids, tryPSin-EDTA so山ion, bovine
albumin fraction V (BSA), aSCOrbic acid and β-glycerophosphate were purchased from
Gibco Laboratories (Be血esda, Maryland).
Culture plates were obtained from Costar (Cambridge, MA)・
A murine calvarial osteoblast MC3T3-EI cell line, SubcIone 14 (CRL-2594) was
Obtained from the American Type Culture Collection (Rockville, MD)・
Hydroxyproline assay reage血S (mono hydrated citric acid, glacial acetic acid, tri-
hydrated sodiun acetate, SOdiun hydroxide, n-PrOPanOl, tOluene, C皿oramine-t, P-
dimethyl-anino-benzaldehyde and 70% perchloric acid) were purchased宜om Fisher
Scientific (Morris Plains, NJ). Cis-4-Hydroxyproline was obtained from Sigma (St. Louis,
MO).
The procollagen C-PrOteinase i血ibitor (BMP I I山部itor) FG1 455 was provided by
FibroGen (South San Francisco, CA, USA). It is a hydroxanic acid of a molecular weight
of 436.5 that binds specifically to the active zinc atom of procollagen C-PrOteinases. It
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specifically i血ibits procollagen C-Proteinase activity with an IC50 of O.1いM・ It is not
cytotoxic to cu血Lred cells for concentrations of up to 60叫M. In our experiment
COnCentrations of 5, 20 and 50叫M were used.
The recombinant hman TNF-α WaS Obtained from PeproTech Inc., Rocky Hi11,
NJ.
2/ E鵬cts of a procollagen C-Proteinase inhibitor on co11agen deposition and lysyl
OXidase
2.1/ Cell culture and harvesting
400,000 MC3T3-EI cells were plated in lOO mm tissue culture dishes and fed with
grow瓜media (DMEM sapplemented with lO% FBS, 0. 1 mM non-eSSential amino acids,
1 00 units/mL of penici11in and l OOいg/mL of streptomycin) until confluenxy・
Growth mediun was removed and replaced with di鮮訂entiation mediun (α一MEM
supplemented with lO% FBS, 0.1 mM non-eSSential amino acids’100 units/mL of
penicillin, 100　鵬/mL of streptomycin, 50　ng/mL ascorbate and lO mM　β-
glycerophosphate) for 48 hours.
Ce11s were re-fed w皿diiferentiation medium supplemented with either 5, 20 and
50いM BMPl i血ibitor or O.1% DMSO as control for 15 or 20 days (media change every
2-3 days).
Cell extracts were hydrolyzed in 12.1 N HCl at l lO C for 22 hours in sealed glass
ampules. Hydrolysates were speed vacuun dried and dissoIved in distilled water t血ee
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times. Aliquots from cell extracts dissoIved in water were used for the measurement of
Pyridinoline crosslinks. Some other aliquots taken from cell extracts dissoIved in the
hydroxyproline bu能汁Were uSed for the measurement of the hydroxyproline content.
2.2/ Measure血ent Of pyridinoline crosslinks
Metra PYD EZ4, an aSSay kit from Quidel (San Diego, CA) was used. It is
designed to measure excreted pyridiniun crosslinks in urine as an indicator of type l
COllagen resoaption in osteoporosis. It is a competitive enzyme immunoassay. Pyd/Dpd
from our sanples competes for a soluble antipyridinium anti-body (cortjugated with
alkaline phosphatase) against Pyd coated on a microtiter plate. After a washing step a p-
nitrophenyl phosphate substrate is added and incubated for an hour. The reaction is
StOPPed with NaOH and optical density is read at 405 rm. Each sanple Pyd plus Dpd
COnCentration is detemined according to a standard curve ran on the sane microtiter
pl加e.
2.3/ Measurement of the co賞lagen content
The hydroxyproline content accounts for 13% of the co11agen weight (Edwards
and O’Brien, 1980). Hydroxyproline levels were therefore detemined by coIorimetric
assays as previously described by Stegemam (Stegemam, 1958), Woesmer (Woessner,
1961) and Edwards (Edwards and O’Brien, 1980).
圏囲護
A Buffer solution has to be prepared to dissoIve the cell extracts and to run the
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For a 500 mL so山ion, 16.6 g of hydrated citric acid, 4 mL ofglacial acetic acid,
40 g of tri-dydrated sodium acetate and l l.375 g of sodium hydroxide were dissoIved in
125 mL of disti11ed water. 100 mL of n-PrOPanOI was added. The so山ion pH was
a4justed to 6-6.5. The so山ion volume was brought to 500 mL with distilled water and
250叫L oftoluene was added. The solution can be stored for up to 2 months in the dark at
40C.
One milliliter of buffer so山ion was added to each dried cell extract hydrolyzate.
Sanples were then di山ed l:5 or l:10 in 2 mL buffer and one more milliter of
buffer was added. Triplicates were made. A chloramine-T solution had to be made fresh
by adding 50 mL ofdistilled water to O.705 g ofchloramine-T・ 1.5 mL ofthe chloranine-
T so山ion were added to each sample tube for 20 minutes at room temperature to oxidize
the free hydroxyproline into pyrrole.
Meanwhile, Ehrlich’s reagent was prepared by mixing 7.5 g of p-DABA, 30 mL n-
PrOPanOl, 13 mL of 70% perc皿oric acid and 7 mL ofdistilled water. 1.5 mL ofE皿ich’s
reagent was added to each sanple tul)e tO allow the production of a red c血omophore
While incubated at 60OC for 20 mim九es. Sample tubes were cooled to room temperature
on ice and their absorbance was measured at 550 rm.
Hydroxyproline standards had to be processed concomita血y in order to be able to
PIot a standard curve血at correlates紬吊れsorbancy at 550 rm to a hydroxyproline
concentration.
0・002 g of cis-4 hydroxyproline were dissoIved in 4 mL of bu舐升SO山ion and 2
mL of the new solution were diluted in 8 mL of buffer solution. Hydroxyproline
concentrations of O, 1, 2, 4, 6 and lO叫g/mL were obtained by di山ing O, 100, 200, 400,
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room temperature. 1・5 mL of E血Iich’s reagent were added to each standard tube. These
tubes were incubated at 60OC for 20 minutes and cool-downed to room temperature on ice.
Absorbance values at　550　rm were pIotted against standard hydroxyproline
C OnCentrati ons.
Hydroxyproline values from血e sanples were detemined from the standard curve
and co11agen content calculated.
This assay is extremely sensitive. Bu鴨r preparation is crucial・ From our
experience Chloramine-T and p-DABA have to be fairly new or the assay won’t work・
3/ Regulation of collagen synthesis by TNF-α
3.11 Cel賞culture and harvesting
350,000 MC3T3 cells were plated in lOO mm tissue culture dishes and fed wi血
growth media (α-MEM supplemented wi血10% FBS, 0. 1 mM non-eSSential amino acids,
100 units/mL of penicillin and l OO叫g/mL of straptomycin) until subconfluency (70% of
Cell density) at 37 Oc in a fu11y humidified atmosphere of 5% CO2 in air. Cells were then
fed with di餌汀entiation medium (Serum free media containing O.1% BSA, 50いg/inL
ascorbate and lO mM β-glycerophosphate) for 24h. Following that the cells were fed with
the same serum free media supplemented or not by TNF一α・
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3.2/ Collagen Synthesis Assay
Subconfluent MC3T3 cells were fed with serum free media supplemented or not
by lO and lOO ng/mL of TNF-α for 24 hours. The cells were subsequently incubated for
2h with serum and proline free a-MEM supplemented with lOいCihuL [2,3 3H] proline in
PreSenCe Of TNF-α. Then, the cells were harvested in O.05 M Tris HCI pH 7.6 on ice and
homogenized (PowerGen 125, fisher Scientific, Morris Plains, NJ). By repeated
PreCipitation with 5% trichloroacetic acid at 4 0c and centrifugation unincorporated
tritiated proline were separated from radioactive proteins. Residual trichloroacetic acid
WaS remOVed by a 3:1 ethanol/ether wash. The pe11et was subsequently air dried and
redissoIved in l N NaOH for 5 minutes. 500叫L of incubation bu節er ( 60 mM HEPES,
0.25 mM CaCl, 1.25mM N-ethylmaleimide) was added to each sample. 100叫L of the
incubated sample were mixed with 5 mL scintillation fluid to measure total incorporated
tritiated proline in a liquid scintillation spectrometer. 200いL of the incubated sample
Were SuPPlemented with 25　叫g/mL of pur描ed bacterial collagenase (Worthington
Biochem., Freehold, N.J.) for 90 minutes at 37 Oc under agitation. The reaction was
StOPPed on ice with lO% TCA and O.5% tamic acid. After 5 minutes of centrifugation at
400 g and 4 Oc the supematant was added to 5 mL scintillation fluid vials. Data for







A fluoremetric assay was perfomed to assess the cell DNA content per lOO mm
tissue culture plate (Vytasek, 1982). MC3T3 0SteOblastic ce11s were scraped in O.01%
triton-X and ce11 1ysates were then homogenized and hydrolyzed with l M perchloric acid
at 70 OC for 20 minutes to release deoxyribose. The pellet was incubated with m-
diaminobenzoic acid. The amount of liberated deoxyribose was measured by




1/ E耽cts of a procoIlagen C-PrOteinase inhibitor on co11agen deposition and
萱ysy量oxidase
Pyridinoline (Pyd) and deoxypyrinoline (Dpd) collagen cross-1ink levels are good
markers of co11agen maturity・ We therefore decided to measure Pyd/Dpd levels in our
OSteOblast like model in the presence or absence of a proco11agen C-PrOteinase inhibitor.
Hong et al・ Showed that “ lysyl oxidase is regulated as a function of d肺erentiation of
MC3T3-EI cells, and that the maximum increase in lysyl oxidase activity precedes the
most e珊cient phase of insoluble collagen accumu量ation x>・ They also found that maximum
insoluble collagen deposition occurs between day 12 and day 15 (Hong et al・, 2004). We
therefore wanted to check crosslinking levels after that peak of maximum deposition and
maximum lysyl oxidase activity. Cells were grown in di任erentiation medium for 15 and
20 days in the presence or absence of the procollagen C葛PrOteinase (BMP-1) inhibitor・
400,000 MC3T3-EI cells were grown in lOO mm tissue culture plates and fed with
growth media until confluency. Subsequently, the grow血mediun was removed and
replaced with di飾erentiation mediun for 48 hours. Cells were re-fed with differentiation
mediun suppleme血ed with either 5, 20 and 50いM of BMPl i血ibitor for 15 or 20 days
(media change every 2置3 days). BAPN or O.1% DMSO (vehicle only) samples served as
controIs. Cell extracts were hydrolyzed in sealed glass anpules containing dydrochloric
acid for 22 hours. Aliquots from cell extracts dissoIved in water were used for the
measurement of pyridinoline crosslinks.
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Untreated (DMSO) and treated (either 5, 20 or 50いM of BMPl i血ibitor) ce11
extracts血om day 15 and day 20 were analyzed by EIA for pyridinoline content versus a
BAPN control.
Our preliminary data (Tables II and IV) showed that only small amounts of mature
crosslinks were detectable in untreated cultures on day 15 0f d肺erentiation (0.2027 ±
0.0099 nmoI per plate) compared to day 20 (0∠r717 ± 0・0389). In both experiments’
BAPN inhibits, aS eXPeCted, the number of mature crosslinks. In Fig. 6 there seems to be a
decreasmg number of mature crosslinks as the inhibitor concentration increases. The
number of mature crosslinks, however, On day 15 of d珊nentiation is so Iow and the
di餌nences between the experimental groups so small’these data may not be conclusive.
We therefore focused for the rest of our experiments on cell extracts from day 20 of
di餌汀entiation only.
In Fig. 7 there seems to be a slight decrease in mature crosslinks as the
concentration of the procollagen C-PrOteinase inhibitor increases・ To further assess the
e蝕鵜ts of the procollagen C-PrOteinase inhibitor on matrix deposition we did one more
experiment with treated (20 and 50 prM of BMP-1 i血ibitor) and u血eated (DMSO) cells
extracts from day 20 of di飾erentiation versus a BAPN control’eaCh one including 3
Cultures per group and quadruplate readings・
Once more the hydrolyzed cel=ysates were su+iected to enzyme immuno assay・
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In this experiment there seems to be increasing amounts of Pyd/Dpd crosslinks
With increasmg COnCentrations of the BMP- 1 inhibitor, Which contradicts our preliminary
data.
In order to have a better understanding of the real picture we decided to normalize
the data to the amount of collagen that could be found in each culture. We know that
hydroxyproline accounts for 13% of the collagen weight (Edwards and O-Brien, 1980). If
We find the hydroxyproline content of each culture it is possible to detemine the total
amount of collagen. In order to do so we perfomed a hydroxyproline assay on both the
treated and untreated hydrolyzed cell extracts from day 20 of differentiation but dissoIved
in l ml of hydroxyproline bu餌汀this time. The hydroxyproline bu節er was carefu11y
PrePared as described in materials and methods. Sanples were then diluted l :10 in 2 ml
buffer and one more milliter of bu舐升WaS added. A chloramine-T solution and the
Ehrlich’s reagent were prepared as described in `Materials and Methods’. 1.5 ml of
Chloranine-T solution was added to each sample tube and incubated for 20 minutes at
room temperature to oxidize the free hydroxyproline into pyrrole. Then l.5 mL of
Ehrlich’s reagent was added to each sample tube to a量low the production of a red
Chromophore while incubating at 60OC for 20 minutes. Samples were cooled down on ice
and their absorbance was measured at 550 nm. Concomitantly, hydroxyproline standards
Were PrOCeSSed as described in `Materials and Methods’in order to be able to pIot a
Standard curve that correlates an absorbancy at 550 nm to a hydroxyproline concentration
(Table IX). Hydroxyproline values fl.om the samples were determined from the standard
CurVe, and the collagen content was calculated.
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Once we had the collagen content of each sample we were able to normalize our
CrOSSlinkage data.
As expected our data shows that BAPN does inhibit the number of mature cross-
1inks in deposited co11agen but’SurPrisingly’the procollagen C-PrOteinase inhibitor at 20
and 50いM did not inhibit the accunulation of mature cross-1inks on day 20 of
differentiation. In this experiment collagen content reported as mean ± Standard deviation
WaS Slightly increased in 50いM of BMP-1 inhibitor (35.6いg ± 7.2) compared to the
DMSO control (34.8叫g ± 9.4).
In preliminary hydroxyproline assays we had found for instance that the total cel=ayer
hydroxypro量ine was more significantly increased in 50いM of BMP-1 inhibitor (78.8叫g ±
26.8) compared to the DMSO control (56.76叫g ± 25.4).
As expected our data shows血at BAPN inhibits mature collagen cross-1ihking. By
inhibiting lysyl oxidase maturation with the BMP-1 i血ibitor we would have expected
SOme effect on collagen maturation and deposition. Our data suggests otherwise・ The
PrOCO11agen C-PrOteinase i血ibitor at 20 and 50叫M may mCreaSe abnormal co11agen
deposition but doesn’t seem to modify much the mature co11agen cross-1inking process.
2/ E鱒ects of TNF-α On COl萱agen deposition and lysyl oxidase
Pischon et al. showed that TNF一α does inhibit collagen accumu量ation in MC3T3-
EI cells cultured for 12 days in the presence of lO and lOO ng/mL of TNF-α (Pischon et
al., 2004). In the second pan of our study we wanted to see what would be TNF-α’s e餌鵜t
On CO11agen synthesis・ 350000 MC3T3-EI cells were grown in lOO mm tissue culttne
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Plates and fed with growth media until near confluency. They were subsequently fed with
d珊erentiation medium for 24 hours. Following that they were fed with the same
differentiation medium supplemented or not with lO or lOO ng/mL of TNF置α for 24
hours. In order to assess the synthesis of newly formed proco11agen a collagen synthesis
assay was performed. Control and experimental groups were pulsed with tritiated proline
for 2 hours as described in `Materials and Methods’. The cells were harvested in O.05 M
Tris HC宣pH 7.6 on ice and homogenized. To separate unincorporated tritiated proline
from radioactive proteins several precipitations with trichloroacetic acid and
Centrifugations were performed. Residual trichloroacetic acid was removed by a 3:1
ethanol/ether wash. The remamlng Pellet was subsequently air dried and redissoIved in l
N NaOH. 500いL of incubation bu餓3r (See `Material and Methods’for more details) was
added to each sample. 100いL of the incubated sample were mixed with 5 mL scinti11ation
fluid to measure total incorporated tritiated proline in a liquid scinti11ation spectrometer
and 200叫L of the incubated sample were supplemented or not with 25叫g/mL of purified
bacterial co11agenase for 90 minutes at 37 Oc under agitation. The reaction was stopped on
ice with lO%　trichloroacetic acid and O.5%　tannic acid. After centrifugation the
SuPematant, Which contains the collagen-derived peptides, WaS added to 5 mL scintillation
fluid vials. Total radioactivity in the samples was calculated in counts per minute (CPM)
as shown in Table XIV. CPM values were multiplied by 5 as only lOOいL out of the 500
叫L of the incubated samples/controIs were used for that assessment.
The amount of collagen derived peptides in the presence or absence of TNF-α WaS
Calculated in counts per minute from our collagenase treated samples (right column in
圃 39
In order to standardize our collagen synthesis data from Table XV we first decided to
nomalize it to the total radioactivity of each sample as seen in table XIV (Table XVI and
Fig. 12).
DNA levels were found to be fairly similar in all treatment groups at 564.73 ±
71・22 (mean ± SD) (table XVⅡ). We therefore decided not to nomalize the collagen
Synthesis data to the total DNA content.
As shown in Fig. 12 we found that collagen synthesis does not seem to be affected
much by TNF一α・ There is a slight decrease in co11agen synthesis when the cells are treated
With lOO ng/mL of TNF-α but it is not statistically significant. In conclusion, TNF-α
doesn’t seem to interfere with co11agen synthesis.
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1/ E値ects of a procollagen C“proteinase inhibitor on co暮lagen depo§ition and lysyl
OXidase
Collagen biosynthesis invoIves multiple steps as seen in part l/ of the introduction.
Procollagen C-PrOteinases (BMP-1) remove血e globular C-PrOPePtide domain of the
maturing procollagen molecule in血e extra-Cellular matrix which a11ows for self
assembly’CrOSSlihking and deposition of the collagen molecules・ BMP-1 or the type I
PrOCOllagen C-PrOteinase is also invoIved in血e maturation of血e 50 kDa pro-1ysyl
OXidase into the active 30 kDa enzyme and an 18 kDa propeptide・ Lysyl oxidase initiates
the mature crosslinking process (See introduction parts 2/ and 3.1.1/) that allows for
COrreCt CO11agen molecules assembly and deposition. BMP-1 plays, therefore, a Central
role in extracellular matrix fomation and deposition・ As a result, any inhibition of BMP葛1
COuld potentially a任ect both extracellular matrix formation and deposition. G山amic acid
derived dydroxamates were identi丘ed as potent and selective i血ibitors of procollagen C-
PrOteinase (BMP-1) (Darkwardt et al., 2001; Robinson et al., 2003). In血e sea-urChin
blastocoele, an hydroxamate derivate compound, FG-HLl (FibroGen, South San
Francisco, CA, USA) was shown to disrupt fibrillar collagen deposition (Huggins and
Lemarz, 2001). Our study goal was to detemine whether inhibition of procollagen C-
PrOteinase would diminish collagen deposition and cross-1inking in bone ce11 cu血res. In
that regard the use of procollagen C-PrOteinase i血ibitors such as hydroxamates
derivatives should give us more infomation・ Maximum insoluble collagen deposition was
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Shown to occur between day 12 and day 15 of d脚光entiation in MC3T3-EI osteoblasts
(Hong et al., 2004). We therefore studied the downstream e餌鵜tS Of a procollagen C-
PrOteinase (BMP-1) hydroxamate inhibitor provided by FibroGen on collagen fomation
and deposition in osteoblast-1ike murine MC3T3-EI cells at both 15 and 20 days of
d聯erentiation・ BMP-1 processes prolysyl oxidase into its mature form・ Pischon et al・
Showed in pulse labeling and immunoprecipitation experiments that the BMP-1 inhibitor
did inhibit the processmg Of lysyl oxidase and resulted in smaller amounts of the mature
30 kDa form (Pischon et al., 2005). As a consequence of the reduced lysyl oxidase
activity we expected to find a decreasing number of mature crosslinks (Pyd/Dpd) with
increasmg COnCentrations of the BMP-1 inhibitor. Our data showed that the proco11agen
C-PrOteinase inhibitor does not reduce the number of Pyd/Dpd crosslinks at both 20 and
50いM. Ei血er the inhibitor is not e飾ective enough or the lysyl oxidase enzyme activity
might be regulated by another pathway. Lysyl oxidase is not the only enzyme i正tiating
the matlure COllagen crosslinking process. Four lysyl oxidase like proteins were recently
described: LOXL (Kenyon et al., 1993; Kim et al., 1995), LOXL2 (Jourdan-Le Saux et
al., 1999), LOXL3 (Maki and Kivirikko, 2001) and LOXL4 (Asuncion et al・, 2001; Ito et
al., 2001). Borel et al. showed that BMP-1 could in-Vitro process LOXL (Borel et al.,
2001). On the other end, LOXL4 was found not to be processed by BMP-1 (Ito et al・,
2001). As far as we know no study showed that LOXL2 and LOXL3 were or were not
PrOCeSSed by BMP-1. Our BMP-1 inhibitor may indeed prevent lysyl oxidase and LOXL
PrOCeSSing and therefore their activity but LOXL4 and possibly LOXL2 and LOXL3 may
COmPenSate for such a loss of activity. The apparent lack of e飾ect of our BMP-1 inhibitor
On the amount of mature crosslinks may therefore be accounted for LOXL4 and possibly
LOXL2 and LOXL3 activities. On the other end, although the nunber of mature
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CrOSSlinks may be cIose to nomal that doesn’t mean that the collagen fibril arrangement
and deposition is nomal. Several authors showed血at collagen宜bril dianeter is increased
by BAPN (Gerstenfeld et al., 1993; Wong et al., 2002) or　-1 (Pischon et al., 2005)
inhibitor treatment. Under proco11agen C-PrOteinase i血ibition, the remaining C-teminal
type I collagen propeptide may interfere with proper aligrment and may explain the
increased宜bril diameter. BMP- 1 inhibitor treatment may therefore interfere with collagen
fibril arrangement and deposition possibly due to the lack of removal of the C-terminal
PrOPePtide rather than a decrease in the number ofmature crosslihks.
2/ E飾ects of TNF“α On CO皿agen deposition and lysyl oxida§e
TNF-α is a pleiotropic cytokine that has multiple e餓弗ts both intracellularly and
extrace11ularly. Intracellularly, TNF-α Can mOdulate the expression of several genes
(Schutze et al., 1992) and transcription factors (See Part 8. 1.5/ of the introduction for more
details). It was shown for instance to inhibit collagen synthesis and incorporation
(Centrella et al., 1988; Panagakos et al., 1994). TNF一α Plays a m年ior role in the host
defense against infections and in the presence of an infection initiates a transient
inflammatory response (Beutler and Cerami, 1989). In some cases like rheumatoid
arthritis or Crohn’s disease TNF一α levels remain high and so does the inflammation.
TNF-α is usually found in low concentrations around chronic inflammatory lesions and
may enhance fibrosis by preventing collagen phagocytis (Chou et al., 1996). In post-
menopausal osteoporosis patients present with decreased bone mass indexes and increased
risks of fracture following ovarian failure. TNF一α levels increase sign縄cantly in the
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absence of estrogen replacement therapy (Pacifici et al., 1991) and inhibition of TNF-α
WaS Shown to prevent bone loss (Kimble et al・, 1997). Overexpression of soluble TNF-α
receptor also prevented bone loss in ovariectomied mice (Ammann et al., 1997)・ Ralston
et al・ Showed that expression of TNF-α at the mRNA level is elevated in osteoporotic and
untreated postmenopausal women than in estrogen replacement therapy postmenopausal
women (Ralston, 1994). Commonly used markers of bone degradation are urinary
pyridinoline (Pyd) and deoxypyridinoline (Dpd) and their levels can be monitored to
a句ust homonal estrogen replacement therapy and prevent or at least reduce osteoporosis
(Seibel et al., 1993). TNF-α’s effects on extrace11ular matrix formation and deposition are
therefore of upmost importance・
In our study we wanted to see what would be the effects of TNF-α treatment On
COllagen biosynthesis・ Our data shows that TNF-α does not seem to a飾ect collagen
synthesis・ Pischon et al・ Showed that TNF-α　treatment reduces both collagen
accumulation in the extracellular matrix and the amount of mature crosslinks in deposited
COllagen (Pischon et al., 2004). Panagakos et al. showed that TNF-α treatment is not
CytOtOXic to the cells and doesn’t interfere with collagen synthesis but induces a
Significant decrease in alkaline phosphatase activity and collagen deposition (Panagakos
et al., 1994). As a result, TNF-α mOSt likely only regulates collagen deposition at the
extracellular level and not intracellularly.
Lysyl oxidase activity was shown to be statistically inhibited at both lO and lOO
ng/mL TNF-α and’aS reSult, the amount of mature collagen crosslinks was also
statistically diminished in both treatment groups (Pischon et al., 2004). Mature co11agen
crosslinks are important for bone integrity and lesser numbers mean less bone
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biomechanical strength. In post-menOPauSal osteoporosis, bone destruction can be
monitored by urinary pyridinoline (Pyd) and deoxypyridinoline (Dpd) levels that are
increased. In the absence of estrogen replacement血erapy, TNF-α 1evels increase and
most likely mediate bone destruction by inhibiting lysyl oxidase activity. Regulatory
mechanisms invoIved in estrogen controI of TNF-α release are not clear. Schurman et al.
evaluated the effects of nitric oxide synthethase (NOS) inhibitors (aminoguanidine) on
both bone resorption and TNF-α release from pre and post menopausal women. They
found that TNF-α levels were significantly higher in postmenopausal than premenopausal
WOmen and that NOS inhibition statistically increased TNF-α 1evels in premenopausal
WOmen. Since estrogen stimulates NOS, they postulated that “estrogen withdrawal may
reduce the inhibitory role of nitric oxide in TNF-α release (Schurman et al., 2001).
Pacifici mentioned another possible mechanism for estrogen lower宣ng effects on TNF-α
PrOduction: eStrOgen aSSOCiated with its β receptor (ERβ) lowers the production of two
AP-1 family transcription factors (C-Jun and JunD) which in tum reduces TNF一α
PrOduction (Pacifici, 1999). Hormonal replacement therapy has been for years the gold
Standard to prevent post menopausal bone loss but increased risks, although co血OVerSial,
Of breast cancer and heart disease have been associated with its use (Castelo-Branco et al.,
2005; Farrell, 2003) and its bene紐s questioned. Since TNF-α is apparently a m年ior factor
invoIved in post-menOPauSal bone degradation and is not cytotoxic to the cells
(Panagakos et al., 1994), drugs targeting TNF-α COuld be used to prevent post-
menopausal bone loss. Ir可ection of a soluble TNF一α reCePtOr by an adenoviral vector to
neutralize TNF-α WaS Shown to statistically reduce bone loss in ovariectomized mice
(Baltzer et al., 2001)・ In patients undergoing breast cancer treatment with aromatase
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inhibitors (Or Other estrogen inhibitors) a statistically increased risk of bone loss was
found (Mincey et al., 2006). A TNF-α targeted drug could possibly reduce that risk.
Another potential e節ect of the TNF-α is reduced lysyl oxidase activity and
subsequently the reduced amount of mature co11agen crosslinks can lead to easier
degradation of the co11agen matrix by collagenases and gelatinases・
3/ Conclusion
As we have seen, inhibition of lysyl oxidase processmg lowers lysyl oxidase
activity but has little or no e飾ect on the amount of collagen mature cross-1inks.
Procollagen C-PrOteinase (BMP-1) inhibition may be limited to lysyl oxidase and some
(LOXL) but not a11 of its isofoms・
On the other end, TNF-α reduces both lysyl oxidase activity and the amount of mature
collagen crosslinks without a鮒鵜ting collagen synthesis. As a result’TNF-α mOSt likely
downregulates lysyl oxidase and its isoforms at the mRNA level. In conclusion’Our Study




In conclusion, the first part of this study shows that inhibition of lysyl oxidase by a
hydroxamate procollagen C-PrOteinase inhibitor at 20 and 50いM doesn’t seem to modify
much the mature collagen cross-1inking process. Other lysyl oxidase like enzymes are
PrObわly invoIved and not a鯖もcted by the inhibitor.
In accordance to previous studies,血e second part of our study shows that TNF-α
doesn’t seem to interfere with collagen synthesis. Regulation of collagen deposition by
TNF-α mOSt likely occurs at the extra-Ce11ular level and not the intra-Cellular level.
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